The Liverpool human immunodeficiency virus (HIV) therapeutic drug monitoring (TDM) registry

Not Applicable

• Conditions: Human immunodeficiency virus; Infections and Infestations; Unspecified human immunodeficiency virus disease

• Registration Number: ISRCTN65117827
• Lead Sponsor: niversity of Liverpool

Brief Summary

2008 Results article in http://www.ncbi.nlm.nih.gov/pubmed/18771051 results 2009 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19228205 results 2009 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19329800 results 2009 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19474786 results 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19897506 results 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20051929 results 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20921307 results 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21364060 results 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20726906 results 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21441248 results 2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21564164 results

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-07-29
• Last Update Posted: 4 October 2021
• Study Completion: 2030-01-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

Request for TDM of HIV drugs

Exclusion Criteria

. Separate filters will be applied when analysing data, e.g. for children, pregnant women, patients on dialysis, patients receiving chemotherapy etc.

Study & Design

• Study Type: Observational
• Study Design: Not specified